- Global Pharma News & Resources

Macular Degeneration Treatment Market Share Size Worth USD 13108.05 Million at a Healthy CAGR, During the Forecast Period 2028

A wide-reaching Macular Degeneration Treatment Market research report brings into focus the key market dynamics of the sector. This market study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, distributors, and Porter’s Five Forces Analysis. The report provides fluctuations in CAGR values during the forecast period of the market. The transformation in the market landscape is mainly observed due to the moves of key players or brands which range from developments, product launches, joint ventures, mergers, and acquisitions that in turn change the view of the global face of the industry.

Macular degeneration treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.80% in the above mentioned forecast period and expected to reach the USD of 13108.05 million by 2028.

Macular degeneration is a neurodegenerative ocular disorder which affects the part of the eye called macula. Degeneration of macula will result in loss of central vision because it provides the sharp and central vision required for seeing the objects clearly. It develops when the capillaries around the fovea dilated and leak. This causes fluid build-up that impairs the reflection of light and cause progressive vision loss. It mostly affects the people of age 50 and 60. This condition is characterised by night blindness, tunnel vision and loss of central vision. It is also known as age-related macular degeneration (AMD).

Rise in the incidence of ocular surface injuries because it can contribute to the neurotrophic keratitis and development of advanced therapies are the major factors influencing the growth of the market. Moreover, huge financial support to the researchers for the development of novel intervention, increase in the special designation for the regulatory authorities and advancement of cell therapy that can improve the vision are the factors that will expand the macular degeneration treatment market.

Growing demand for novel treatment and hug investment on research and development activities will provide beneficial opportunities for the Macular degeneration treatment market in the forecast period of 2021-2028.

Download Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @

Global Macular Degeneration Treatment Market Scope and Market Size

The Macular degeneration treatment market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

On the basis of type, the Macular degeneration treatment market is segmented into wet macular degeneration and dry macular degeneration.

On the basis of treatment, the Macular degeneration treatment market is segmented into drugs and surgery. Drugs have been further sub-segmented into ranibizumab, aflibercept and others. Surgery has been further sub-segmented into laser photocoagulation surgery and subretinal surgery.

On the basis of route of administration, the Macular degeneration treatment market is segmented into oral, injectable and others.

On the basis of end-users, the Macular degeneration treatment market is segmented into hospitals, homecare, specialty clinics, ophthalmic clinic and others.

The Macular degeneration treatment market is also segmented on the basis of distribution channel into hospital pharmacies, retail pharmacies and online pharmacies.

Macular Degeneration Treatment Market Country Level Analysis

Macular degeneration treatment market is analyzed and market size information is provided by the country, type, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Macular degeneration treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the Macular degeneration treatment market due to the presence of major key players, rise in the prevalence of eye disorders, increasing geriatric population, favourable reimbursement policies and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the rise in the prevalence macular degeneration, surge in the investment for healthcare sector, growing awareness and increase in the disposable income.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

To Get a Detailed Table of Contents (TOC), please Click Here at @

Patient Epidemiology Analysis

Macular degeneration treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Macular Degeneration Treatment Market Share Analysis

Macular degeneration treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to macular degeneration treatment market research.

The major players covered in the Macular degeneration treatment market report are Adverum Biotechnologies Inc., Neurotech, Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd, Allergan, Regeneron Pharmaceuticals, Inc, STEMCELL Technologies Inc, IVERIC bio, Inc., SANWA KAGAKU KENKYUSHO CO.,LTD., Bausch Health Companies Inc., Alcon Vision LLC, Phio Therapeutics Corp., Kubota Pharmaceutical Holdings Co., Ltd, Bayer AG, Novartis AG, Opthea, Santen Pharmaceutical Co., Ltd, PanOptica, Inc, and Resolvyx Pharmaceuticals, Inc, among other domestic and global players.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Detailed Summary of Research Report @

Customization Available: Global Macular Degeneration Treatment Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Top Trendings Reports:-

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability levels and advanced approaches. We are committed to uncovering the best consumer prospects and fostering useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expanded its reach by opening a new office in the Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Editor Details

  • Company:
    • The Wire Times
Last Updated: 22-Nov-2022